Latest Period
Q1 2026
Security Snapshot
Coya Therapeutics, Inc. - Common Stock, $0.0001 par value per share (COYA) Institutional Ownership
CUSIP: 22407B108
13F Institutional Holders and Ownership History from Q4 2022 to Q1 2026
Institutions Reporting
57
Shares (Excl. Options)
8,132,603
Price
$3.94
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Common Stock, $0.0001 par value per share
- Symbol
- COYA on Nasdaq
- All holders as of 31 Mar 2026
- Q1 2026
- Total 13F shares
- 8,132,603
- Total 13F value
- $32,048,898
- Portfolio coverage rank
- 0%
- Share change
- +101,577
- Value change
- -$1,369,168
- Number of holders
- 57
- Shares outstanding
- 23,430,175
- SEC-reported price per share
- $4.77
- Insider filing price
- $4.77
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
3 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- COYA - Coya Therapeutics, Inc. - Common Stock, $0.0001 par value per share is tracked under CUSIP 22407B108.
- 57 institutions reported positions in Q1 2026.
- 4 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 58 to 57 between Q4 2025 and Q1 2026.
- SEC-reported value moved from $46,046,406 to $32,048,898.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 57 institutions filings for Q1 2026.
Security key
22407B108
Latest holder period
Q1 2026
13F holders
57
13D/G owners
4
CIK / CUSIP context first
Open Q1 2026 holders
COYA full holder history
Coya Therapeutics, Inc. SEC filings
Coya Therapeutics, Inc. company facts
Coya Therapeutics, Inc. insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 22407B108:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
4
Security
COYA
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Dr. Reddy's Laboratories, Inc. | 9.7% | $10,727,271 | 2,272,727 | Dr. Reddy's Laboratories, Inc. | 30 Jan 2026 | |||
| DME Capital Management, LP | 9.9% | $10,783,903 | 1,651,440 | DME Advisors GP, L.L.C. | 31 Dec 2024 | |||
| HIRSCHMAN ORIN | 5.3% | -34% | $6,427,392 | -$1,309,338 | 1,108,171 | -17% | Orin Hirschman | 31 Dec 2025 |
| VANGUARD GROUP INC | 4.3% | $5,215,012 | 899,140 | The Vanguard Group | 31 Dec 2025 |
As of 31 Mar 2026, 57 institutional investors reported holding 8,132,603 shares of Coya Therapeutics, Inc. - Common Stock, $0.0001 par value per share (COYA). This represents 35% of the company’s total 23,430,175 outstanding shares.
13F concentration
Top 25 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
33%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| DME Capital Management, LP | 10% | 2,335,540 | +15% | 0.29% | $9,202,027 |
| AIGH Capital Management LLC | 4.2% | 975,404 | 0% | 0.79% | $3,843,092 |
| VANGUARD CAPITAL MANAGEMENT LLC | 3.6% | 844,913 | 0% | 0% | $3,328,957 |
| Alyeska Investment Group, L.P. | 3.4% | 800,000 | 0% | 0.01% | $3,152,000 |
| Prosight Management, LP | 1.8% | 420,360 | 0.27% | $1,656,218 | |
| CM Management, LLC | 1.6% | 375,000 | +7.1% | 1.2% | $1,477,500 |
| PRIVATE MANAGEMENT GROUP INC | 1.6% | 369,096 | +32% | 0.04% | $1,454,238 |
| GEODE CAPITAL MANAGEMENT, LLC | 1% | 233,402 | +18% | 0% | $919,783 |
| MARSHALL WACE, LLP | 0.96% | 225,792 | +0.19% | 0% | $889,621 |
| VANGUARD FIDUCIARY TRUST CO | 0.6% | 139,886 | 0% | 0% | $551,151 |
| RENAISSANCE TECHNOLOGIES LLC | 0.44% | 103,964 | +55% | 0% | $409,618 |
| PRELUDE CAPITAL MANAGEMENT, LLC | 0.43% | 101,330 | +94% | 0.03% | $399,240 |
| JBF Capital, Inc. | 0.43% | 100,006 | 0% | 0.06% | $394,024 |
| DIMENSIONAL FUND ADVISORS LP | 0.41% | 95,919 | +205% | 0% | $377,251 |
| MORGAN STANLEY | 0.37% | 85,700 | +61% | 0% | $337,658 |
| BlackRock, Inc. | 0.35% | 82,769 | +4.6% | 0% | $326,110 |
| STATE STREET CORP | 0.34% | 79,813 | +15% | 0% | $314,463 |
| 683 Capital Management, LLC | 0.3% | 70,000 | -13% | 0.03% | $275,800 |
| XTX Topco Ltd | 0.2% | 47,338 | +43% | 0% | $186,512 |
| JONES FINANCIAL COMPANIES LLLP | 0.19% | 44,960 | +786% | 0% | $178,042 |
| ADAR1 Capital Management, LLC | 0.17% | 40,900 | 0.01% | $161,146 | |
| Squarepoint Ops LLC | 0.17% | 40,465 | -38% | 0% | $159,432 |
| NORTHERN TRUST CORP | 0.17% | 40,418 | 0% | 0% | $159,247 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 0.17% | 39,316 | -69% | 0% | $154,905 |
| Long Corridor Asset Management Ltd | 0.17% | 38,766 | 0% | 0.04% | $152,738 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
14
Latest
Q1 2026
Rows shown
1-14 of 14
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q1 | 8,132,603 | $32,048,898 | -$1,369,168 | $3.94 | 57 |
| 2025 Q4 | 7,939,025 | $46,046,406 | +$18,480,971 | $5.80 | 58 |
| 2025 Q3 | 4,755,804 | $27,110,326 | +$1,543,439 | $5.70 | 35 |
| 2025 Q2 | 4,484,686 | $25,787,239 | -$1,022,977 | $5.75 | 33 |
| 2025 Q1 | 4,662,591 | $30,167,676 | +$1,480,613 | $6.47 | 26 |
| 2024 Q4 | 4,444,580 | $25,467,940 | +$6,454,839 | $5.73 | 26 |
| 2024 Q3 | 3,315,161 | $21,385,210 | +$304,078 | $6.45 | 19 |
| 2024 Q2 | 3,268,292 | $19,805,900 | -$932,467 | $6.06 | 19 |
| 2024 Q1 | 3,339,060 | $33,123,748 | +$5,311,359 | $9.92 | 19 |
| 2023 Q4 | 2,822,037 | $20,644,859 | +$10,288,077 | $7.41 | 20 |
| 2023 Q3 | 1,416,355 | $5,449,280 | +$229,488 | $3.84 | 14 |
| 2023 Q2 | 1,351,642 | $5,500,530 | +$1,016,457 | $4.07 | 13 |
| 2023 Q1 | 1,101,849 | $4,368,596 | +$41,079 | $3.97 | 7 |
| 2022 Q4 | 1,091,417 | $5,156,354 | +$5,156,354 | $4.74 | 4 |